Member Info for Laura2022

Fantastic market opportunities $$$

Anyone able to put a value on this going forward

2 contracts did indeed come as Pete said on 7th "high level of confidence "

Pete imho is transforming the pipeline and sharpening the focus which maybe JM had lost

Ant was spot on for 20th May post here

 I think we will soon get notification of both contract sign offs, an update on the new BioStats Division and quite possibly an indication of successful outcomes from the conferences. As I have said previously PYC are in the right space at the right time Lets give PS a chance to prove himself rather than second guess, as at least one negative poster is hell bent on doing. News will soon propel the share price as with all AIM stocks and we are very undervalued irrespective recent announcements by the company. I am more than happy to defend their position and the Company's future which in my opinion if bright.

We all do

And your answers to your questions on comments on contracts are there on the past 4mths

And yes, we qll want success but the strange behaviours and ignoring from several posters was very odd

That's now £950k of contracts won in the fukl year (albeit these last 2 reveneues fall into upcoming financial year. That's the largest ever

Starting 2025 with £0.5mln and a pipeline of at least £1.5mln suggests upcoming year will be another record, as for volume if seems people willing to chase all kinds of nonsense on AIM at the moment particularity non producing dubuius resource companies !

Even stranger is still no comment from Ant15 on either contract

More nonsense from fishman Ilovesushi

He's a total liar

I'm not getting any prices on HL

Largest ever single contract and now the last 3 contracts (£125k £170k and £186k) are much larger than the average for 2022-2023

Awarded a new contract by an existing, large client. The project involves the use of our proprietary Virtual Tumour platform to model the client's targeted oncology agents in combination with other modalities to help inform dose and scheduling decisions. The value of the contract is £186k and it is anticipated that it will be completed over the course of the current calendar year.  This project and associated contract award is the second of the two referred to in the Company's trading update on 3 May 2024 and now means that the Company will be going into its next financial year ending 30 June 2025 with committed revenues of over £0.5m.

Good morning everyone

Yes, from the link provided by King h and subsequent comments by Trench it certainly looks Mike something is progressing or else why would PYC comment just 10 days after the DoseMeRx article

Hope you get this back trading amd recover the lost money

Good luck to you all here

The Board has also discovered that, on 3 June 2024, payments totalling almost $400k were made from the bank account of the Group's US subsidiary to Antonio Russo and Trevor Taylor's personal US bank accounts. These payments were not approved by the Board and were not notified to the Board at their meeting held on the day. The Company's Board is seeking a proper explanation from Trevor Taylor and Antonio Russo for these payments, and the recovery of these funds through all legal means available.

· The Board is examining the involvement of certain advisers appointed by Mr Russo and Mr Taylor in facilitating the actions outlined above. The Board will take appropriate action in relation to any misfeasance

Workers at the historic Harland and Wolff shipyard in Belfast have voted in favour of industrial action.

The GMB union said members voted with a 98% majority after the company failed to make a pay offer for the year 2024/25.

Staff members are due to meet with H&W representatives on Tuesday afternoon.

In recent months, the union said internal disagreements within the Government were scaring workers after it was reported the shipyard could close – despite winning a £1.6bn Royal Navy contract.

It was reported in May that Chancellor Jeremy Hunt was expected to block a £200m taxpayer-backed financial support package designed to keep the shipyard afloat.

It led to fears that without the package, the 162-year-old firm could collapse – but this was rubbished by Harland & Wolff in recent months

Could this be a real breakthrough into a large financial opportunity

May 30, 2024 09:00 AM Eastern Daylight Time

JUPITER, Fla.--(BUSINESS WIRE)--DoseMe, a leading provider of model-informed precision dosing (MIPD), is pleased to announce that its flagship product, DoseMeRx, has filed the necessary application for a CE certificate with the notified body for MDR Conformity, ahead of the May 26, 2024, deadline.

What does the link mean please King H

I don't know what this means exactly but seems a good fit PYC /DoseMeRx

About DoseMe:

DoseMe combines smart technology with science, leveraging clinically-validated PK/PD models, patient characteristics, drug concentrations, and genotype to accurately individualize a dose in seconds. The platform is HIPAA, ISO & FDA compliant and the only Bayesian dosing platform to be HITRUST CSF certified.

Trench makes a good point kingH

And to be fair in March the company did day this

Company remains in close contact with DoseMe regarding how it can progress its collaboration focused on the commercialisation of the Company's dosing tool in the US and further announcements on this will be made when appropriate.

We're proud to be working alongside @DoseMeApp to advance personalised cancer care. By leveraging mathematical modelling & clinical decision support software, we empower clinicians with the tools & insights they need to deliver the best possible treatments to every patient.